Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Bangladesh
  4. Dhaka Stock Exchange
  5. Renata Limited
  6. News
  7. Summary
    RENATA   BD0457RENAT6

RENATA LIMITED

(RENATA)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Renata Limited completed the acquisition of unknown remaining shares of Renata Oncology Limited.

07/26/2020 EDT

Renata Limited (DSE:RENATA) signed an agreement to acquire unknown remaining shares of Renata Oncology Limited on October 29, 2019. Under the terms of transaction, the exchange of 0.02 shares of Renata Limited for each share of Renata Oncology Limited. The transaction is subject to approval of consent of creditors, shareholders and approval from the Honorable High Court division of Supreme Court of Bangladesh and other legal/regulatory authorities. On November 14, 2019, the board of Renata Limited approved the transaction. Renata Limited (DSE:RENATA) completed the acquisition of unknown remaining shares of Renata Oncology Limited on July 26, 2020. The Hon'ble High Court Division of the Supreme Court of Bangladesh has sanctioned the Scheme of Amalgamation of Renata Oncology Limited with Renata Limited on July 26, 2020.


ę S&P Capital IQ 2020
All news about RENATA LIMITED
05/01Renata Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021
CI
02/01Renata Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020
CI
2020RENATA LIMITED : 10% Stock Dividend
FA
2020RENATA LIMITED : Ex-dividend day for final dividend
FA
2020Renata Limited Reports Earnings Results for the First Quarter Ended September 30, 2020
CI
2020Renata Limited Recommends Dividend for the Year Ended June 30, 2020
CI
2020Renata Limited completed the acquisition of unknown remaining shares of Renata Oncology..
CI
2020Renata Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020
CI
2020Renata Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019
CI
2019RENATA LTD. : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2021 28 112 M 332 M 332 M
Net income 2021 4 767 M 56,2 M 56,2 M
Net cash 2021 3 143 M 37,1 M 37,1 M
P/E ratio 2021 29,4x
Yield 2021 1,02%
Capitalization 141 B 1 656 M 1 658 M
EV / Sales 2021 4,89x
EV / Sales 2022 4,17x
Nbr of Employees 7 710
Free-Float 86,1%
Chart RENATA LIMITED
Duration : Period :
Renata Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 1 441,90 BDT
Average target price 1 184,50 BDT
Spread / Average Target -17,9%
EPS Revisions
Managers and Directors
Syed S. Kaiser Kabir CEO, Managing Director & Director
Khokan Chandra Das Chief Financial Officer
Sarwar Ali Chairman
Rakibul Mohammed Huq Head-Information Technology
Nehal Ahmed Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RENATA LIMITED30.26%1 654
JOHNSON & JOHNSON3.68%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY34.09%210 037